蜜桃视频

蜜桃视频

  • May 14, 2025

    ITC To Probe Nokia Patent Claims Against Acer And Others

    The ITC has voted to investigate a patent complaint by Nokia against Acer, Asus and Hisense after the telecom giant accused them of infringing its patents with their video-capable laptops, desktop computers, handheld computers, tablets, televisions, projectors and components and module products.

  • May 14, 2025

    Potential Jurors In IP Hot Spots Hold Mixed Views On Big Tech

    A survey of possible jurors in popular courts for intellectual property cases has found their overall outlook on Big Tech to be largely positive, but also found that many believe that tech giants will swipe technology from smaller businesses and that they suppress competition.

  • May 14, 2025

    Alnylam Halts Patent Row Over Pfizer, BioNTech COVID-19 Vax

    Alnylam Pharmaceuticals has decided to end a district court patent case over the COVID-19 vaccine made by Pfizer and BioNTech, asking a Delaware federal judge Tuesday to rule that the companies do not infringe its mRNA patents, while potentially setting the stage for an appeal.

  • May 14, 2025

    Objectors Give Thumbs-Down To Latest Fix In NIL Settlement

    The exceptions to the roster limits rule added to the NCAA's $2.78 billion settlement over college athlete compensation for name, image and likeness failed to fix the damage the rule causes for several current and prospective athletes, objectors told a California federal judge in demanding that the latest settlement revision be rejected.

  • May 14, 2025

    ExxonMobil Accuses Texas Atty Of Double Repping Company

    Exxon Mobil and XTO Energy have accused a Texas attorney of taking their trade secrets connected to mineral interests and using them to benefit another energy company he is also representing.

  • May 14, 2025

    Stewart Orders PTAB Officials To Review Axed LED Patent

    Acting U.S. Patent and Trademark Office Director Coke Stewart has ordered a panel of Patent Trial and Appeal Board leaders to review whether a Polaris LED driver patent was properly invalidated.

  • May 14, 2025

    EU Wrong To Deny Dutch Tax Firm's Trademark, Court Says

    A Dutch consultancy was wrongly denied a trademark for "Taxmarc" in the European Union after a German consultancy that controlled a trademark for "X Taxman" opposed its registration, the European General Court said Wednesday.

  • May 14, 2025

    Vape Co. Stopped From Using 'Breeze' Name

    A Michigan federal judge has blocked a New Jersey company from marketing products with the name "Breeze" in a trademark dispute with a competitor in the vaping industry.

  • May 14, 2025

    Walmart Hit With $223M Verdict In Trade Secrets Fight

    An Arkansas federal jury has awarded Zest Labs Inc. nearly $223 million聽in a suit that had accused Walmart of swiping the startup's trade secrets related to shelf-freshness technology.

  • May 14, 2025

    Biogen Sues Ex-Collaborator Over Rights To Drug Tech

    Biogen said its partner on a since-shelved Alzheimer's drug is trying to claim rights to an unrelated novel therapeutic that the Massachusetts company recently shared with the Swiss partner under a confidentiality agreement, according to a lawsuit filed Tuesday.

  • May 13, 2025

    PTAB Ramps Up Fintiv Denials After Withdrawal Of Memo

    Weeks after the U.S. Patent and Trademark Office withdrew a memo that limited when patent challenges could be rejected based on parallel litigation, the Patent Trial and Appeal Board has denied dozens of petitions by citing upcoming trials, mostly in the Eastern District of Texas.

  • May 13, 2025

    Atty Sues To Sell NFL Merch Without License

    The NFL is facing another lawsuit from an attorney seeking a court order saying he is allowed to sell unlicensed NFL merchandise and asserting that the league's effective monopoly on its merchandising is not based on trademark law.

  • May 13, 2025

    Brie, Franco's 'Together' Is 'Blatant Rip-Off,' Film Co. Says

    Production company StudioFest alleged in California federal court on Tuesday that the upcoming horror film "Together," starring real-life spouses Alison Brie and Dave Franco, is a "blatant rip-off" of a movie it pitched to the couple's agents in 2020.

  • May 13, 2025

    Becton Dickinson Sues Baxter Over Infusion Pump Patents

    Becton Dickinson has accused Baxter International of willfully infringing six of its patents for infusion pump technologies used to deliver medications to patients, telling a Delaware federal court that marketing materials for a Baxter infusion pump platform touted several Becton inventions.

  • May 13, 2025

    Did AI Co. Anthropic's聽Expert Cite AI-Hallucinated Study?

    Music publishers claiming artificial intelligence company Anthropic infringed their works to train its AI models told a California federal magistrate judge Tuesday that an Anthropic expert witness cited a "fictitious" AI-generated study in a recently filed declaration, urging the judge to sanction the company's Latham & Watkins attorneys for not catching the issue.

  • May 13, 2025

    Hose Maker Wants Case Over Amazon Patent Program Tossed

    An expandable garden hose maker wants a Delaware federal court to throw out a suit seeking a declaration that a Chinese company isn't infringing a pair of patents, saying it never made any infringement allegation against the Chinese company.

  • May 13, 2025

    10x Genomics, Bruker Strike Deal After $31M Patent Verdict

    Gene sequencing technology firm 10x Genomics and scientific instrument maker Bruker Corp. have reached a settlement in a patent infringement lawsuit that previously led biotechnology company NanoString to file for Chapter 11 bankruptcy relief.

  • May 13, 2025

    Split PTAB Cites SAS To Reject Samsung Petition

    The Patent Trial and Appeal Board will not review whether a real-time interpretation patent for those hard of hearing is invalid after finding that only a quarter of Samsung's challenge could be successful, which isn't worth the full trial mandated by the U.S. Supreme Court.

  • May 13, 2025

    Cancer Centers Want Fed. Circ. To Rehear Antibody IP Fight

    The Dana-Farber Cancer Institute and Memorial Sloan-Kettering Cancer Center say the full Federal Circuit should review a decision rejecting Xencor's application for an antibody patent, arguing that the decision wrongly created a new precedent that could be harmful to other patents.

  • May 13, 2025

    Investment Firm Drops 2 Counts From $70M Client Poach Suit

    Connecticut investment firm TJT Capital Group LLC has agreed to drop a Computer Fraud and Abuse Act count and a common-law trade secrets misappropriation claim from a lawsuit accusing a chief compliance officer of taking $70 million in assets under management with him when he left for a new job.

  • May 13, 2025

    Betting Cos. Feud Over Stay As Discovery Sanctions Loom

    A sportsbook technology company being sued by a former collaborator for allegedly stealing trade secrets has asked a Nevada federal court to reject efforts to stay the case as it pursues sanctions against the plaintiff for allegedly withholding key evidence.

  • May 13, 2025

    Albright Scraps $26M Video Patent Verdict Against Google

    U.S. District Judge Alan Albright has overruled a jury's $26 million verdict against Google LLC and its YouTube LLC subsidiary for infringing VideoShare LLC's video sharing patent, finding that as a matter of law "the only reasonable interpretation of the claim language" shows no infringement.

  • May 13, 2025

    MoFo DQ Sought In IP Case After Perkins Coie Ouster

    A software developer pursuing intellectual property claims against another technology company in San Francisco federal court has followed through with its threat to seek removal of Morrison & Foerster LLP after it succeeded in disqualifying Perkins Coie LLP, arguing the firms worked closely together and new counsel is necessary to avoid prejudice.

  • May 12, 2025

    Fed. Circ. Erases MIT, Broad CRISPR Win In Conception Fight

    The Nobel Prize-winning scientists who lost their interference proceeding on a key use of the gene-editing technology CRISPR persuaded the Federal Circuit on Monday to鈥 give them another chance, with the court providing clarity on how to analyze conception.

  • May 12, 2025

    Mariah Carey's $186K Fee Bid Is BigLaw Fantasy, Atty Says

    An attorney for two songwriters who unsuccessfully sued Mariah Carey encouraged a California federal judge Monday not to impose the full amount of a nearly $186,000 sanctions bid against him and his clients who had alleged Carey's hit "All I Want for Christmas Is You" was stolen from their song.

Expert Analysis

  • Evidence Rule May Expand Use Of Out-Of-Court Statements

    Author Photo

    A proposed amendment to Federal Rule of Evidence 801(d)(1)(A) would broaden the definition of nonhearsay, reflects a more pragmatic approach to regulating the admissibility of out-of-court statements by declarant-witnesses, and could help level the playing field between prosecutors and criminal defendants, say attorneys at Hangley Aronchick.

  • Series

    Racing Corvettes Makes Me A Better Lawyer

    Author Photo

    The skills I use when racing Corvettes have enhanced my legal practice in several ways, because driving, like practicing law, requires precision, awareness and a good set of brakes 鈥 complete with the wisdom to know how and when to use them, says Kat Mateo at Olshan Frome.

  • Opinion

    Attorneys Must Act Now To Protect Judicial Independence

    Author Photo

    Given the Trump administration's recent moves threatening the independence of the judiciary, including efforts to impeach judges who ruled against executive actions, lawyers must protect the rule of law and resist attempts to dilute the judicial branch鈥檚 authority, says attorney Bhavleen Sabharwal.

  • The Math Of Cross-Examination: Less Is More, More Is Less

    Author Photo

    When conducting cross-examination at trial, attorneys should remember that 鈥渓ess is more, and more is less鈥 鈥 limiting both the scope of questioning and the length of each query in order to control the witness鈥檚 testimony and keep the factfinders鈥 attention, says Thomas Innes at the Defender Association of Philadelphia.

  • Rethinking 'No Comment' For Clients Facing Public Crises

    Author Photo

    鈥淣o comment鈥 is no longer a cost-free or even a viable public communications strategy for companies in crisis, and counsel must tailor their guidance based on a variety of competing factors to help clients emerge successfully, says Robert Bowers at Moore & Van Allen.

  • 9th Circ. Draws The Line On Software As A Derivative Work

    Author Photo

    The Ninth Circuit's recent decision in Oracle International v. Rimini Street clarifies the meaning of derivative work under the Copyright Act, and when a work based upon a preexisting item doesn't constitute a derivative, says John Poulos at Norton Rose.

  • How Design Thinking Can Help Lawyers Find Purpose In Work

    Author Photo

    Lawyers everywhere are feeling overwhelmed amid mass government layoffs, increasing political instability and a justice system stretched to its limits 鈥 but a design-thinking framework can help attorneys navigate this uncertainty and find meaning in their work, say law professors at the University of Michigan.

  • Tools For Witness Control That Go Beyond Leading Questions

    Author Photo

    Though leading questions can be efficient and effective for constraining a witness鈥檚 testimony, this strategy isn鈥檛 appropriate for every trial and pretrial scenario, so techniques like headlining and looping can be deployed during direct examination, depositions and even witness interviews, says Allison Rocker at Baker McKenzie.

  • Trending At The PTAB: Insights From 2024 Fed. Circ. Statistics

    Author Photo

    Looking at stats from the Federal Circuit's decisions in 219 Patent Trial and Appeal Board appeals last year sheds light on potential trends and strategy considerations that could improve appeals' chances of success, say attorneys at Finnegan.

  • Opinion

    Admin Change May Help Reduce PTAB Invalidation Rates

    Author Photo

    It is not good for the U.S. patent system that the Patent Trial and Appeal Board finds all challenged claims to be unpatentable 70% of the time 鈥 but new leadership at the Commerce Department and U.S. Patent and Trademark Office may foster pro-patent policies and provide some relief, says Stephen Schreiner at Carmichael IP.

  • 4 Do's And Don'ts For Trial Lawyers Using Generative AI

    Author Photo

    Trial attorneys who use artificial intelligence tools should review a few key reminders, from the likelihood that prompts are discoverable to the rapid evolution of court rules, to safeguard against embarrassing missteps, says Nate Sabri at Perkins Coie.

  • Defense Strategies For Politically Charged Prosecutions

    Author Photo

    Politically charged prosecutions have captured the headlines in recent years, providing lessons for defense counsel on how to navigate the distinct challenges, and seize the unique opportunities, such cases present, says Kenneth Notter at MoloLamken.

  • Series

    Competitive Weightlifting Makes Me A Better Lawyer

    Author Photo

    The parallels between the core principles required for competitive weightlifting and practicing law have helped me to excel in both endeavors, with each holding important lessons about discipline, dedication, drive and failure, says Damien Bielli at VF Law.

  • 3 Potential Developments That May Alter US Patent Rights

    Author Photo

    The Federal Circuit's upcoming decision in EcoFactor v. Google, pending legislation before Congress and the appointment of a new U.S Patent and Trademark Office director all have significant potential to strengthen or weaken patent rights, say attorneys at McKool Smith.

  • Opinion

    Inconsistent Injury-In-Fact Rules Hinder Federal Practice

    Author Photo

    A recent Third Circuit decision, contradicting a previous ruling about whether consumers of contaminated products have suffered an injury in fact, illustrates the deep confusion this U.S. Supreme Court standard creates among federal judges and practitioners, who deserve a simpler method of determining which cases have federal standing, says Eric Dwoskin at Dwoskin Wasdin.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the 蜜桃视频 archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!